Cas:191729-45-0 Tenacissoside H manufacturer & supplier

Chemical Name:Tenacissoside H

CAS.NO:191729-45-0

Synonyms:(3β,5α,11α,12β,14β,17α)-12-Acetoxy-3-{[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-β-D-allopyranosyl)-3-O-methyl-β-D-arabino-hexopyranosyl]oxy}-20-oxo-8,14-epoxypregnan-11-yl 2-meth ylbutanoate;Butanoic acid, 2-methyl-, (3β,5α,11α,12β,14β,17α)-12-(acetyloxy)-3-[[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-β-D-allopyranosyl)-3-O-methyl-β-D-arabino-hexopyranosyl]oxy]-8,14-ep oxy-20-oxopregnan-11-yl ester;Tenacissoside H

Molecular Formula:C₄₂H₆₆O₁₄

Molecular Weight:794.965

HS Code:29389090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:815.4±65.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.551

PSA:178.04000

Exact Mass:794.445251

LogP:4.73

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (3β,5α,11α,12β,14β,17α)-12-Acetoxy-3-{[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-β-D-allopyranosyl)-3-O-methyl-β-D-arabino-hexopyranosyl]oxy}-20-oxo-8,14-epoxypregnan-11-yl 2-meth ylbutanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Tenacissoside H physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Butanoic acid, 2-methyl-, (3β,5α,11α,12β,14β,17α)-12-(acetyloxy)-3-[[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-β-D-allopyranosyl)-3-O-methyl-β-D-arabino-hexopyranosyl]oxy]-8,14-ep oxy-20-oxopregnan-11-yl ester Use and application,(3β,5α,11α,12β,14β,17α)-12-Acetoxy-3-{[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-β-D-allopyranosyl)-3-O-methyl-β-D-arabino-hexopyranosyl]oxy}-20-oxo-8,14-epoxypregnan-11-yl 2-meth ylbutanoate technical grade,usp/ep/jp grade.

Related News: EMA said the drug can help improve the respiratory function of Pompe disease patients, and the most common side effects include hypersensitivity (including anaphylaxis) and infusion-associated reactions. 1-Bromo-2-(bromomethyl)-4-methoxybenzene manufacturers Israel was a world leader in the vaccination rollout, with many seniors getting their shots in December, January and February as they were regarded as the most vulnerable sector of the population. 6-methoxy-2-methylquinolin-4-ol suppliers He said it is “normal” for scientists and clinicians to discuss and debate data from experiments and clinical trials, but added those discussions have taken a turn “outside the boundaries of legitimate scientific deliberation.” 3-O-Benzyl-1,2-O-isopropylidene-α-D-glucofuranose vendor & factory.